Susan Quaggin
Fortune : 793 154 $ au 31/05/2026
Fortune : 793 154 $ au 31/05/2026
Dr. Susan E.
Quaggin, MD, is an Independent Director at AbbVie, Inc., a Director & Chief Scientific Officer at Mannin Research, Inc. and a Professor at Feinberg School of Medicine.
She is on the Board of Directors at AbbVie, Inc., American Society of Nephrology and Mannin Research, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 3 643 ( 0% ) | 793 154 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ABBVIE INC. | Directeur/Membre du Conseil | 11/10/2023 |
Mannin Research, Inc.
Mannin Research, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Fondateur | - |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Directeur/Membre du Conseil | - |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Health Services |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mannin Research, Inc.
Mannin Research, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national